Levothyroxine Treatment in Pregnancy: Indications, Efficacy, and Therapeutic Regimen

Liu, L., Yu, Y., Zhao, M., Zheng, D., Zhang, X., Guan, Q., Xu, C., Gao, L., Zhao, J., & Zhang, H. (2017). Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients. International Journal of Endocrinology, 2017(), 1-10. https://doi.org/10.1155/2017/5753039
Babu, R. P., Christy, A., Hegde, A., Manjrekar, P., & D'Souza, V. (2015). Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?. Clinical Medicine Insights: Women’s Health, (2015), 1-6. https://doi.org/10.4137/CMWH.S22114
Duryea, E., Nicholson, F., Cooper, S., Roberts, S., Rogers, V., McIntire, D., Sheffield, J., & Stewart, R. (2015). The Use of Protease Inhibitors in Pregnancy: Maternal and Fetal Considerations. Infectious Diseases in Obstetrics and Gynecology, 2015(), 71-75. https://doi.org/10.1155/2015/563727
李耀泰、陳福民、郭宗正（2013）。What is the Best Regimen of Methotrexate for Low-Risk Gestational Trophoblastic Disease?。中華民國婦癌醫學雜誌，(2013年1)，92-99。https://www.airitilibrary.com/Article/Detail?DocID=10195998-201304-201305160004-201305160004-92-99
Haas, D. M., McHugh, K. W., Durst, P. J., Rose, S. M., & Patil, A. S. (2015). Psychotropic Medications in Pregnancy and the Postpartum Period. Clinical Medicine Insights: Therapeutics, 2015(), 25-32. https://doi.org/10.4137/CMT.S18902